SEC 13F Intelligence

Greystone Financial Group, LLC / GSK

Greystone Financial Group, LLC’s Gsk PLC Position

Does Greystone Financial Group, LLC own Gsk PLC (GSK)? Not currently — the last reported position was 176.7K shares worth $7M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$7M
Q2 2024
Shares
176.7K
% of Portfolio
+1.33%
Quarters Held
8
position exited

Position History GSK

Reported value by quarter
Q3 ’22: $628,000Q3 ’22Q4 ’22: $730,420Q4 ’22Q1 ’23: $671,466Q1 ’23Q2 ’23: $667,110Q2 ’23Q3 ’23: $715,575Q3 ’23Q4 ’23: $724,597Q4 ’23Q1 ’24: $10MQ1 ’24Q2 ’24: $7MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 2024176.7K$7M+1.33%
Q1 2024243.8K$10M+2.09%
Q4 202319.6K$724,597+0.17%
Q3 202319.7K$715,575+0.18%
Q2 202318.7K$667,110+0.15%
Q1 202318.9K$671,466+0.17%
Q4 202220.8K$730,420+0.21%
Q3 202221.3K$628,000+0.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Greystone Financial Group, LLC’s full portfolio or all institutional holders of GSK.